Skip to product information
1 of 1

LR3-IGF-I Protein, Salmon

LR3-IGF-I Protein, Salmon

Catalog Number: UA040556 Brand: UA BIOSCIENCE
Price:
Regular price $95 USD
Regular price Sale price $95 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Salmon
Synonyms LR3 Insulin-like Growth Factor-I, MGF, IGFI, IGF1A, IGF, IBP1
Accession Q91476
Amino Acid Sequence

Gly19-Ala88 (Glu21Arg)

Expression System E.coli
Molecular Weight

10-12 kDa (Reducing)

Purity >95% by SDS-PAGE & HPLC.
Endotoxin <0.1EU/μg
Conjugation Unconjugated
Tag No Tag
Physical Appearance Lyophilized powder
Storage Buffer

PBS, pH7.4

Reconstitution

Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

Stability & Storage

·12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
·3 months, -20 to -80℃ under sterile conditions after reconstitution.
·1 week, 2 to 8℃ under sterile conditions after reconstitution.
·Please avoid repeated freeze-thaw cycles.

Reference

Endocrinology. 1999 Oct;140(10):4699-705.
J Neurotrauma. 2018 Jul 1;35(13):1467-1480.

Background

IGF-I is a well-characterized basic peptide secreted by the liver that circulates in the blood. It has growth-regulating, insulin-like, mitogenic activities. IGF-I is a growth factor that has a major, but not absolute, dependence on somatotropin. It is believed to be mainly active in adults in contrast to IGF-II, which is also a major fetal growth factor. Salmon Long R3 Insulin-like Growth Factor-I contains a 70 amino acid analog of Salmon IGF-I. Compared to the complete IGF-I sequence, an addition of the LR3-IGF-1 includes the substitution of an Arg for the Glu at position 3 (hence R3) and a 13 amino acid extension peptide at the N-terminus. An enhanced potency is due to the markedly decreased binding of Long R3-IGF-I to IGF binding proteins which normally inhibit the biological actions of IGFs.

Picture

Bioactivity

Determined by a cell proliferation assay using serum free human MCF-7 cells. The EC50 is 0.71-1.8 ng/ml.

SDS-PAGE

2μg (R: reducing condition, N: non-reducing condition).

SEC-HPLC

>95% as determined by SEC-HPLC.